[1]王功硕,夏婷婷,史家欣*.间充质干细胞在急性呼吸窘迫综合征及2019冠状病毒病中的应用展望[J].徐州医科大学学报,2022,42(03):231-234.[doi:10.3969/j.issn.2096-3882.2022.03.014]
 Application prospect of mesenchymal stem cells in acute respiratory distress syndrome and coronavirus disease 19[J].Journal of Xuzhou Medical University,2022,42(03):231-234.[doi:10.3969/j.issn.2096-3882.2022.03.014]
点击复制

间充质干细胞在急性呼吸窘迫综合征及2019冠状病毒病中的应用展望()
分享到:

《徐州医科大学学报》[ISSN:2096-3882/CN:32-1875/R]

卷:
42
期数:
2022年03期
页码:
231-234
栏目:
出版日期:
2022-03-25

文章信息/Info

Title:
Application prospect of mesenchymal stem cells in acute respiratory distress syndrome and coronavirus disease 19
作者:
王功硕夏婷婷史家欣*
徐州医科大学附属连云港医院呼吸与危重症医学科,江苏连云港222006
关键词:
间充质干细胞急性呼吸窘迫综合征细胞外囊泡2019冠状病毒病
分类号:
R563.8
DOI:
10.3969/j.issn.2096-3882.2022.03.014
文献标志码:
A
摘要:
急性呼吸窘迫综合征(ARDS)是临床常见危重症,各种感染如严重急性呼吸综合征(SARS)、2019冠状病毒病(COVID-19)均可表现为ARDS,其死亡率高,缺乏有效治疗手段。间充质干细胞(MSC)作为一种新型的治疗方法,在临床前及临床研究中表现出较强的抗炎和组织修复能力,其安全性也得到了部分证实,是治疗ARDS的潜在有效措施之一。
Abstract:
Acute respiratory distress syndrome (ARDS) is a common and critical clinical disease. Various infections such as severe acute respiratory syndrome (SARS), coronavirus disease 19 (COVID-19) can cause ARDS. ARDS has a high mortality rate and lacks effective treatment methods. Mesenchymal stem cells(MSC), as a new treatment method, shows strong anti-inflammatory and tissue repair ability in preclinical and clinical studies, and its safety has also been partially confirmed, which is one of the potential effective measures to treat ARDS. This review will review the application of MSC in ARDS and COVID-19.

相似文献/References:

[1]程书立,柳彩侠*.早期高容量血液滤过治疗重症急性胰腺炎伴急性呼吸窘迫综合征疗效观察[J].徐州医科大学学报,2017,37(10):653.
 CHENG Shuli,LIU Caixia*.Effects of early high-volume hemofiltration on severe acute pancreatitis patients with respiratory distress syndrome[J].Journal of Xuzhou Medical University,2017,37(03):653.
[2]顾维立,张成亮,徐志华*.晚期糖基化终末产物受体与ARDS患者预后的关系[J].徐州医科大学学报,2018,38(01):33.
 GU Weili,ZHANG Chengliang,XU Zhihua*.The relationship between the receptor for advanced glycation end-products and the prognosis of ARDS patients[J].Journal of Xuzhou Medical University,2018,38(03):33.
[3]丰炳峰、董晨、关凤军.全骨髓法培养大鼠骨髓间充质干细胞及其生物学特性[J].徐州医科大学学报,2009,29(04):226.
 [J].Journal of Xuzhou Medical University,2009,29(03):226.
[4]荆鑫、赵剑、祝云利等.pcDNA3-EGFP基因转染骨髓间充质干细胞的实验研究[J].徐州医科大学学报,2001,21(06):468.
 [J].Journal of Xuzhou Medical University,2001,21(03):468.
[5]韩扣兰、邱海波、谭焰等.控制性肺膨胀对急性呼吸窘迫综合征家兔血流动力学和气体交换的影响[J].徐州医科大学学报,2002,22(03):189.
 [J].Journal of Xuzhou Medical University,2002,22(03):189.
[6]康丽娟、关凤军、董展等.胚胎后肾间充质干细胞的分离和生物学特性研究[J].徐州医科大学学报,2011,31(07):483.
 [J].Journal of Xuzhou Medical University,2011,31(03):483.
[7]程书立、许继元、李茂琴等.短时间血液滤过对重症急性胰腺炎并发ARDS的辅助治疗作用[J].徐州医科大学学报,2013,33(05):302.
 [J].Journal of Xuzhou Medical University,2013,33(03):302.
[8]王骥、周海军、董红燕等.人外周血间充质干细胞向肝样细胞诱导分化的实验研究[J].徐州医科大学学报,2012,32(08):491.
 [J].Journal of Xuzhou Medical University,2012,32(03):491.
[9]提俊响、韩冠杰、李家琼、李茂琴、许铁.气道压力释放通气减轻急性呼吸窘迫综合征肺损伤[J].徐州医科大学学报,2015,35(02):78.
[10]朱湘芸、王洵、赵弘卿.重症病毒性肺炎合并急性呼吸窘迫综合征预后危险因素探讨[J].徐州医科大学学报,2016,36(02):127.
 [J].Journal of Xuzhou Medical University,2016,36(03):127.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81300052);江苏省六大人才高峰项目(2019-SWYY-324);江苏省青年医学重点人才项目(QNRC2016504);连云港市卫健委项目(202016);南京医科大学康达学院项目(KD2020KYJJYB022)*通信作者,E-mail:shijiaxin909@126.com
更新日期/Last Update: 2022-05-09